Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 3Pharmathen SA
02 2Mankind Pharma
03 6A. Menarini
04 2ANI Pharmaceuticals Inc
05 2ARTHUR GRP
06 2Accord healthcare
07 2Actavis Inc
08 3Adamed Pharma
09 2Ajanta Pharma Limited
10 2Alkem Laboratories
11 2Amneal Pharmaceuticals
12 4Ascent Innovative Medicines
13 2Aurobindo Pharma Limited
14 3CHEMO
15 2Cadila Pharmaceuticals
16 2Chartwell Pharmaceuticals llc
17 2Cipla
18 3DOC Generici
19 3EG Spa
20 2Glenmark Pharmaceuticals
21 2Hetero Drugs
22 1Ind Swift Laboratories Limited
23 4Intas Pharmaceuticals
24 2KYE PHARMACEUTICALS INC.
25 3Krka
26 3LeBasi Pharmaceuticals CC
27 2MENARINI INTL
28 9Menarini
29 2Micro Labs Limited
30 2Novast Laboratories
31 1Pantson Pharma Pvt. Limited
32 2Piramal Pharma Solutions
33 2Rising Pharmaceuticals Inc
34 2ScieGen Pharmaceuticals
35 2Spil
36 2Sun Pharmaceutical Industries Limited
37 2Sunshine Lake Pharma
38 2Teva Pharmaceutical Industries
39 2Torrent Pharmaceuticals Limited
40 5Unichem Laboratories Limited
41 2Unichem Pharmaceuticals USA, Inc
42 2VKT Pharma
43 1Vega Biotech Pvt. Ltd.
44 1Viatris
45 2i3 Pharmaceuticals
01 5ER Tablet
02 1EXTENDED RELEASETABLET
03 3Extended Release Tablet
04 12Extended Release Tablets
05 2GRANULES, EXTENDED RELEASE;ORAL
06 3PROLONGED-RELEASE TABLET
07 3Prolonged Release Tablet
08 3Prolonged-Release Tablet
09 1Ranolazina 375Mg 60 Units Oral Use Rp
10 1Ranolazina 500Mg 60 Units Oral Use Rp
11 1Ranolazina 750Mg 60 Units Oral Use Rp
12 3Ret Tabl
13 3Ret Tablet
14 3SRT
15 1TABLET
16 2TABLET (EXTENDED-RELEASE)
17 54TABLET, EXTENDED RELEASE;ORAL
18 1Tabl
19 5Tablet
20 4XR Tablet
01 14DISCN
02 7Generic
03 3Originator
04 2Prescription
05 40RX
06 45Blank
01 2ASPRUZYO SPRINKLE
02 2CORZYNA
03 1Cyclokapron
04 1Nefazor
05 5RANEXA
06 3RANOLAZINA DOC GENERIC
07 3RANOLAZINA EG
08 3RANOLAZINA KRKA
09 52RANOLAZINE
10 3RANOZEK
11 1Ranazine 500 SR
12 12Ranexa
13 1Ranexa 375 mg
14 1Ranexa 500 mg
15 1Ranexa 750 mg
16 20Blank
01 2Canada
02 3Greece
03 16India
04 18Italy
05 3South Africa
06 3Spain
07 3Sweden
08 7Switzerland
09 56USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 375MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2020-02-12
Application Number : 212284
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 750MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2020-02-12
Application Number : 212284
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-05-28
Application Number : 208862
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2019-05-28
Application Number : 208862
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-05-28
Application Number : 210054
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2019-05-28
Application Number : 210054
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2020-11-30
Application Number : 209953
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2020-11-30
Application Number : 209953
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2021-03-11
Application Number : 207690
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2021-03-11
Application Number : 207690
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-10-29
Application Number : 210482
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2019-10-29
Application Number : 210482
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2022-12-23
Application Number : 209081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2022-12-23
Application Number : 209081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-08-19
Application Number : 210188
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2019-08-19
Application Number : 210188
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2013-07-29
Application Number : 201046
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2013-07-29
Application Number : 201046
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-07-05
Application Number : 211082
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2023-09-27
Application Number : 210668
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2023-09-27
Application Number : 210668
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number : 208174
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1000MG
Packaging :
Approval Date :
Application Number : 208174
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2025-02-04
Application Number : 210407
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2025-02-04
Application Number : 210407
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANEXA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2007-02-12
Application Number : 21526
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANEXA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2006-01-27
Application Number : 21526
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
